Merck v. Gnosis

Summary Judgment Reply - When Defendant's Advertising is More Aligned with the International Standard than Plaintiff's, that is not False Advertising!


This is a Response to a sur reply in a Lanham Act false advertising case in SDNY. Plaintiff, Merck Eprova, claimed that my client, Gnosis, S.p.A., caused an independent GRAS panel of experts to change the nomenclature in their report to better its position in the litigation. Merck claimed that the independent panel started off using Merck's nomenclature but changed it to be more closely aligned with Gnosis' litigation position regarding nomenclature. A couple of major problems:

-First, the independent panel admitted that the nomenclature was confusing. Merck's burden in the case is to prove that the nomenclature is unambiguous.

-Second, the original nomenclature was not consistently Merck's; it was all over the board, showing confusion not clarity.

-Third, the nomenclature did not go from Merck's to Gnosis; it went from a mixture to the internationally recognized International Union of Pure and Applied Chemistry ("IUPAC") nomenclature.

-Fourth - and most importantly - Merck is now accusing Gnosis of changing the nomenclature from Merck's to the IUPAC's, which Merck admits is "more closely aligned" with the nomenclature Gnosis used and Merck claims is literally false.

Question: How can the nomenclature be "more closely aligned" with the worldwide standard and be "literally" false?

LOADING PDF: If there are any problems, click here to download the file.

Reference Info:Legal Memoranda: Motions for Summary Judgment/Adjudication | Federal, 2nd Circuit, New York | United States

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© William Chapman, Julander, Brown, Bollard & Chapman | Attorney Advertising

Written by:


Julander, Brown, Bollard & Chapman on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.